| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789915 | Urologic Oncology: Seminars and Original Investigations | 2018 | 6 Pages |
Abstract
BLC increases detection rates of carcinoma in-situ and papillary lesions over WLC alone and can change management in 14% of cases. Repeat use of HAL for BLC is safe.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Siamak M.D., Soroush T. M.D., Trinity J. M.D., Ph.D., Jeffrey M. M.D., Brian M.D., Jennifer M. M.D., M.P.H., Joseph C. M.D., Kamal M.D., James M.D., Badrinath M.D., M.B.A.,